US Stock MarketDetailed Quotes

PMVP PMV Pharmaceuticals

Watchlist
  • 1.610
  • 0.0000.00%
Close Nov 22 16:00 ET
83.31MMarket Cap-1610P/E (TTM)

PMV Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
11.51%21.89M
0.24%20.17M
-15.17%18.22M
4.01%80.13M
-10.68%18.9M
1.31%19.63M
12.51%20.12M
15.37%21.48M
32.16%77.04M
14.56%21.16M
Selling and administrative expenses
-18.22%4.94M
-11.74%5.54M
-21.41%5.04M
-3.21%24.25M
-10.05%5.52M
5.83%6.04M
-2.24%6.28M
-5.54%6.41M
14.92%25.05M
-2.66%6.14M
-General and administrative expense
-18.22%4.94M
-11.74%5.54M
-21.41%5.04M
-3.21%24.25M
-10.05%5.52M
5.83%6.04M
-2.24%6.28M
-5.54%6.41M
14.92%25.05M
-2.66%6.14M
Research and development costs
24.74%16.95M
5.67%14.63M
-12.52%13.19M
7.50%55.89M
-10.94%13.38M
-0.59%13.59M
20.77%13.84M
27.35%15.07M
42.46%51.99M
23.49%15.03M
Operating profit
-11.51%-21.89M
-0.24%-20.17M
15.17%-18.22M
-4.01%-80.13M
10.68%-18.9M
-1.31%-19.63M
-12.51%-20.12M
-15.37%-21.48M
-32.16%-77.04M
-14.56%-21.16M
Net non-operating interest income expense
-12.37%2.62M
3.89%2.8M
26.97%2.95M
208.00%11.17M
76.18%3.17M
165.48%2.98M
346.36%2.7M
915.28%2.33M
707.80%3.63M
1,595.28%1.8M
Non-operating interest income
-12.37%2.62M
3.89%2.8M
26.97%2.95M
208.00%11.17M
76.18%3.17M
165.48%2.98M
346.36%2.7M
915.28%2.33M
707.80%3.63M
1,595.28%1.8M
Other net income (expense)
2,925.00%121K
-183.33%-17K
-103.70%-1K
-96.55%3K
-205.00%-21K
-69.23%4K
80.65%-6K
165.85%27K
314.29%87K
185.71%20K
Other non- operating income (expenses)
2,925.00%121K
-183.33%-17K
-103.70%-1K
-96.55%3K
-205.00%-21K
-69.23%4K
80.65%-6K
165.85%27K
314.29%87K
185.71%20K
Income before tax
-15.10%-19.15M
0.26%-17.39M
20.17%-15.27M
5.96%-68.96M
18.55%-15.76M
8.76%-16.64M
-0.69%-17.43M
-3.78%-19.13M
-26.81%-73.33M
-5.37%-19.35M
Income tax
74K
-404,425.00%-16.17M
0
122.22%2K
-1K
0
300.00%4K
0
-139.13%-9K
0
Net income
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-26.75%-73.32M
-5.37%-19.35M
Net income continuous Operations
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-26.75%-73.32M
-5.37%-19.35M
Minority interest income
Net income attributable to the parent company
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-26.75%-73.32M
-5.37%-19.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-26.75%-73.32M
-5.37%-19.35M
Basic earnings per share
-8.82%-0.37
94.74%-0.02
28.57%-0.3
10.56%-1.44
27.91%-0.31
15.00%-0.34
0.00%-0.38
-2.44%-0.42
-25.78%-1.61
-7.50%-0.43
Diluted earnings per share
-8.82%-0.37
94.74%-0.02
28.57%-0.3
10.56%-1.44
27.91%-0.31
15.00%-0.34
0.00%-0.38
-2.44%-0.42
-25.78%-1.61
-7.50%-0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 11.51%21.89M0.24%20.17M-15.17%18.22M4.01%80.13M-10.68%18.9M1.31%19.63M12.51%20.12M15.37%21.48M32.16%77.04M14.56%21.16M
Selling and administrative expenses -18.22%4.94M-11.74%5.54M-21.41%5.04M-3.21%24.25M-10.05%5.52M5.83%6.04M-2.24%6.28M-5.54%6.41M14.92%25.05M-2.66%6.14M
-General and administrative expense -18.22%4.94M-11.74%5.54M-21.41%5.04M-3.21%24.25M-10.05%5.52M5.83%6.04M-2.24%6.28M-5.54%6.41M14.92%25.05M-2.66%6.14M
Research and development costs 24.74%16.95M5.67%14.63M-12.52%13.19M7.50%55.89M-10.94%13.38M-0.59%13.59M20.77%13.84M27.35%15.07M42.46%51.99M23.49%15.03M
Operating profit -11.51%-21.89M-0.24%-20.17M15.17%-18.22M-4.01%-80.13M10.68%-18.9M-1.31%-19.63M-12.51%-20.12M-15.37%-21.48M-32.16%-77.04M-14.56%-21.16M
Net non-operating interest income expense -12.37%2.62M3.89%2.8M26.97%2.95M208.00%11.17M76.18%3.17M165.48%2.98M346.36%2.7M915.28%2.33M707.80%3.63M1,595.28%1.8M
Non-operating interest income -12.37%2.62M3.89%2.8M26.97%2.95M208.00%11.17M76.18%3.17M165.48%2.98M346.36%2.7M915.28%2.33M707.80%3.63M1,595.28%1.8M
Other net income (expense) 2,925.00%121K-183.33%-17K-103.70%-1K-96.55%3K-205.00%-21K-69.23%4K80.65%-6K165.85%27K314.29%87K185.71%20K
Other non- operating income (expenses) 2,925.00%121K-183.33%-17K-103.70%-1K-96.55%3K-205.00%-21K-69.23%4K80.65%-6K165.85%27K314.29%87K185.71%20K
Income before tax -15.10%-19.15M0.26%-17.39M20.17%-15.27M5.96%-68.96M18.55%-15.76M8.76%-16.64M-0.69%-17.43M-3.78%-19.13M-26.81%-73.33M-5.37%-19.35M
Income tax 74K-404,425.00%-16.17M0122.22%2K-1K0300.00%4K0-139.13%-9K0
Net income -15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M-26.75%-73.32M-5.37%-19.35M
Net income continuous Operations -15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M-26.75%-73.32M-5.37%-19.35M
Minority interest income
Net income attributable to the parent company -15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M-26.75%-73.32M-5.37%-19.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M-26.75%-73.32M-5.37%-19.35M
Basic earnings per share -8.82%-0.3794.74%-0.0228.57%-0.310.56%-1.4427.91%-0.3115.00%-0.340.00%-0.38-2.44%-0.42-25.78%-1.61-7.50%-0.43
Diluted earnings per share -8.82%-0.3794.74%-0.0228.57%-0.310.56%-1.4427.91%-0.3115.00%-0.340.00%-0.38-2.44%-0.42-25.78%-1.61-7.50%-0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data